The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those ...

Rates of both MCI and composite of MCI or probable dementia lower with intensive treatment in extended follow-up study ...

Increased postoperative opioid consumption was associated with higher probability of new persistent opioid use in opioid-naive patients.

(HealthDay News) — For patients with overweight or obesity and type 2 diabetes, dapagliflozin plus regular calorie restriction is associated with a significantly higher rate of remission of diabetes ...

A patient-centered approach is recommended to tailor to individual needs when calculating individual protein needs.

(HealthDay News) — Women have a higher risk for developing long COVID than men, according to a study published online in JAMA Network Open.

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

(HealthDay News) — Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a study published online in Medicine.

(HealthDay News) — Heart disease continues to be a leading cause of death, according to a report from the American Heart Association published online in Circulation.

However, it offers no additional benefit than the Mediterranean diet alone for abdominal fat. (HealthDay News) — Time-restricted eating (TRE) may not add additional benefit in visceral adipose ...

“Our data suggest SGLT2 inhibition as a safe strategy to prevent kidney stone recurrence in patients with kidney stones ,” Dr Fuster’s team concluded. Other study findings indicate the empagliflozin ...

(HealthDay News) — Adults aged 18 to 49 years reporting medical-only or medical-nonmedical cannabis use may have a higher prevalence of cannabis use disorder (CUD) than those reporting nonmedical only ...